Innate Pharma SA Other Current Receivables
Innate Pharma SA (IPHYF) had Other Current Receivables of EUR 117.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Receivables
ifrs-full:OtherCurrentReceivables · last filed 2026-04-01
- 2025-12-31: Other Current Receivables 117.00K EUR.
- 2025-06-30: Other Current Receivables 146.00K EUR.
- 2024-12-31: Other Current Receivables 89.00K EUR.
- 2024-06-30: Other Current Receivables 97.00K EUR.
| Period end | Other Current Receivables |
|---|---|
| 2025-12-31 | 117.00K EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 146.00K EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 89.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 97.00K EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 104.00K EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 109.00K EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 61.00K EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 78.00K EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 814.00K EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 68.00K EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 741.00K EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 544.00K EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 108.58M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 139.00K EUR 20-F · filed 2020-04-24 |